NTS_QECH

<b>Background</b>The Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) has undertaken sentinel surveillance of bloodstream infection and meningitis at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi for 20 years. Previously, three epidemics of <i>Salmonella </i>bloodstream infection have been identified. Here we provide updated surveillance data on invasive non-typhoidal <i>Salmonella</i> disease from 2011 – 2019. <b>Methods</b>Surveillance data describing trends in invasive non-typhoidal <i>Salmonella</i> disease and associated antimicrobial susceptibility profiles are presented for the period January 2011 – December 2019. <b>Results</b>Between January 2011-December 2019, 128,588 blood cultures and 40,769 cerebrospinal fluid cultures were processed at MLW. 1.00% of these were positive for <i>S.</i> Typhimurium, 0.10% for <i>S.</i> Enteritidis, and 0.05% positive for other <i>Salmonella </i>species. Estimated minimum incidence of iNTS disease decreased from 21/100,000 per year in 2011 to 7/100,000 per year in 2019. Over this period, 26 confirmed cases of<i> Salmonella</i> meningitis were recorded (88.5% <i>S.</i> Typhimurium). Between 2011-2019 there was a substantial decrease in proportion of <i>S.</i> Typhimurium (78.5% to 27.7%) and <i>S. </i>Enteritidis (31.8% in 2011 to 0%) that were multidrug-resistant. Resistance to fluoroquinolones and 3^rd generation cephalosporins (3GC) remained uncommon, however 3GC increased amongst <i>Salmonella</i> spp. and <i>S</i>. Typhimurium in the latter part of the period. <b>Conclusions</b>The total number of iNTS bloodstream infections decreased between 2011-2019. Although the number MDR <i>S.</i> Typhimurium and <i>S.</i> Enteritidis isolates has fallen, the number of MDR isolates of other <i>Salmonella </i>spp. has increased, including 3GC isolates.